Has anybody looked at how badly the country of Spain is doing. Their financial numbers, despite contributing almost nothing to NATO and their military defense, are absolutely horrendous. Sad to watch!!!
https://truthsocial.com/@realDonaldTrump/116425653087220924
Lefty love boat: Greta Thunberg’s freedom flotilla rocked by sexual misconduct allegations
Greta Thunberg’s freedom flotilla, which set sail from Barcelona Sunday for another anti-Israel voyage to Gaza, has been rocked by scandal after one of its woke leaders was accused of “sexual misconduct” with at least three volunteers.
“A senior leader within the flotilla — a member of the steering committee, the highest governing body of the organization — engaged in sexual relations with multiple activists while on the boat heading to Gaza. Not one person. Not two. Three different individuals,” claimed Palestinian group Heart of Falastin in a social media post earlier this week.
https://nypost.com/2026/04/18/world-news/greta-thunbergs-freedom-flotilla-rocked-by-sexual-misconduct-allegations/?utm_medium=social&utm_source=twitter&utm_campaign=nypost
John Thune obstructs again
John Thune’s Senate has delayed weaponization prosecutors in John Brennan probe for two months
Despite a February 23, 2026 deadline, the Republican-led Senate has failed to provide the Justice Department with transcripts and records regarding former CIA Director John Brennan, delaying a grand jury investigation into alleged weaponization of intelligence tools. Senate Majority Leader John Thune has avoided a floor vote to transmit evidence by seeking unanimous consent, a move that contrasts with the compliant House and has strained relations with President Trump.
While Brennan denies wrongdoing, claiming a political witch hunt, Acting Attorney General Todd Blanche has intensified the probe in Florida by appointing former U.S. Attorney Joseph diGenova as lead prosecutor. The DOJ specifically seeks unredacted materials concerning the 2017 Intelligence Community Assessment, the Steele dossier, and Russian collusion allegations.
https://justthenews.com/government/congress/satjohn-thunes-senate-has-delayed-weaponization-prosecutors-john-brennan-probe?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost
Truth
Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
Results: The cohort represented a diverse clinical profile of cancer patients, with mean age of 67 years and nearly balanced sex distribution (52.3% male, 47.7% female). Cancer types included prostate (27.9%), breast (18.3%), lung (8.6%), colon (5.1%), urologic (4.6%), pancreatic (3.0%), liver (2.5%), gynecologic (2.5%), and hematologic (2.5%) malignancies. At enrollment, participants had a median duration since initial diagnosis of 1.2 years, with 37.1% experiencing active disease progression. At 6-month follow-up, medication adherence was high with 86.9% of participants completing the full initial 90-capsule ivermectin-mebendazole prescription and 66.4% remaining on the protocol at 6 months. The Clinical Benefit Ratio (CBR) was 84.4% (95% CI: 77.0–89.8%). Notably, 48.4% (95% CI: 39.7–57.1%) of the cohort reported the strongest positive outcomes, consisting of regression (15.6%; 95% CI: 10.2–23.0%) or no current evidence of disease (NED, 32.8%; 95% CI: 25.1–41.5%). Disease stability was reported to be maintained in 36.1% (95% CI: 28.1–44.9%) of participants, while 15.6% (95% CI: 10.2–23.0%) reported disease progression. While 25.4% reported mild side effects (primarily gastrointestinal), 93.6% of those affected continued treatment through minor dose adjustments. Some participants reported concurrent conventional therapies, including chemotherapy (27.9%), radiation therapy (21.3%), and surgery (19.7%), as well as adjunctive interventions such as supplement use (49.2%), dietary modification (37.7%), and other integrative approaches.
Conclusions: In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumor regression or no current evidence of disease across a heterogeneous population of cancer patients. These findings provide a compelling clinical signal that these well-tolerated, repurposed agents may offer therapeutic benefit. However, given the observational design, reliance on self-reported outcomes, and potential for selection bias and uncontrolled confounding, these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials are warranted to validate these observations and further define optimal dosing strategies.
https://zenodo.org/records/19455636
Thune has orders to delay, obstruct and lay traps to stop Trump in everyway! 😡😡😡😡 Obama must have something on him that needs to be found!